oxymatrine has been researched along with Breast Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Li, H; Li, M; Tan, Z; Wu, J; Zhang, Y | 1 |
| Lin, HS; Pei, YX; Qi, X; Xu, WR; Zhang, Y; Zhu, XY | 1 |
| Li, D; Lin, B; Zhang, L | 1 |
| Hou, W; Hua, B; Lin, H; Pei, Y; Piao, B; Qi, X; Xu, W; Zhang, Y; Zhu, X | 1 |
4 other study(ies) available for oxymatrine and Breast Cancer
| Article | Year |
|---|---|
Oxymatrine Promotes S-Phase Arrest and Inhibits Cell Proliferation of Human Breast Cancer Cells in Vitro through Mitochondria-Mediated Apoptosis.
Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 3; Caspase 9; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Mitochondria; Poly(ADP-ribose) Polymerases; Quinolizines | 2017 |
[Oxymatrine Diminished the Side Population and Inhibited Wnt/p-catenin Signaling Pathway in MCF- 7 Breast Cancer Cells].
Topics: Alkaloids; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; MCF-7 Cells; Quinolizines; Wnt Signaling Pathway | 2016 |
Oxymatrine mediates Bax and Bcl-2 expression in human breast cancer MCF-7 cells.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Dose-Response Relationship, Drug; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Proto-Oncogene Proteins c-bcl-2; Quinolizines | 2016 |
Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells.
Topics: Alkaloids; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplastic Stem Cells; Quinolizines; Side-Population Cells | 2011 |